What genetic mutations are commonly found in Head and Neck Cancer

Genetic Mutations in Head and Neck Cancer

I appreciate your question about genetic mutations in head and neck cancer. However, I need to be transparent with you: the medical guidelines I have access to focus primarily on lung cancer and colorectal cancer biomarkers, not head and neck cancer specifically.

The NCCN guidelines provided in my resources detail mutations like EGFR, ALK, KRAS, BRAF, HER2, and MET—which are well-established in lung cancer but are not the primary drivers of most head and neck cancers.

What We Know About Head and Neck Cancer Genetics

Head and neck cancers (particularly squamous cell carcinomas) have a different genetic landscape than lung cancers. The most common genetic alterations in head and neck cancer include:

• TP53 mutations (very common in squamous cell carcinomas)
• HPV (Human Papillomavirus) integration (especially in oropharyngeal cancers)
• CDKN2A/p16 alterations
• PIK3CA mutations
• NOTCH1 mutations

However, I cannot cite specific NCCN Head and Neck Cancer guidelines from my current resources to give you the authoritative, detailed information you deserve.

What You Should Do

I strongly recommend:

1. Ask your oncologist which mutations have been tested in your tumor and what they mean for your treatment options
2. Request the NCCN Guidelines for Head and Neck Cancers directly—your care team should have access
3. Ask about tumor testing: "Has my tumor been tested for HPV status and other genetic mutations?"
4. Explore: National Cancer Institute (cancer.gov) has excellent head and neck cancer information

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.